Lexeo Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Lexeo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Lexeo Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lexeo Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.7M | 250k | 6.64 |
| 2025-06-30 | $1.1M | 272k | 4.02 |
| 2025-03-31 | $111k | 32k | 3.47 |
| 2024-12-31 | $336k | 51k | 6.58 |
| 2024-09-30 | $101k | 11k | 9.04 |
| 2024-06-30 | $50k | 3.1k | 16.04 |
| 2024-03-31 | $163k | 10k | 15.68 |